罗万特科学
ROIV
33.53
-0.51
-1.50%
罗万特科学
US · ROIV
#747 按市值排名
上市于 1970
33.53
-0.51
-1.50%
实时 - 追踪5344个代码 - 心跳于559秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了3家。
- 机构持股总比例下降了0.3个百分点。
机构持股
- 机构持股比例
- 78.62% -0.35pp
- 机构数量
- 578 -3
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund50.57%
Individual/Insider18.73%
Hedge Fund18.61%
Public Company3.80%
VC/PE Fund2.27%
Private Company1.64%
Government Pension Fund0.72%
Sovereign Wealth Fund0.66%
Insurance Company0.16%
Family Office/Trust0.15%
Other2.85%
主要股东 截至 2026-06-30
Dan Oren
13.59% · 98.17M 股
FMR
11.19% · 80.83M 股
BlackRock
6.68% · 48.24M 股
Morgan Stanley Investment Management Inc.
5.46% · 39.45M 股
Vivek Ramaswamy
3.54% · 25.53M 股
Vanguard Capital Management, LLC
3.46% · 25.02M 股
QVT Financial LP
3.28% · 23.72M 股
Vanguard Portfolio Management, LLC
3.00% · 21.64M 股
State Street Global Advisors
2.46% · 17.80M 股
UBS Asset Management
2.42% · 17.48M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 16次买入 · 34次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Vivek Ramaswamy | Former Chairperson | 3.54% |
| Daniel Gold | Independent Director | 1.24% |
| Eric Venker | President | 0.19% |
| Frank Torti | Vant Chair | 0.04% |
| Mayukh Sukhatme | President & Chief Investment Officer | 0.04% |
| Matthew Gline | Chief Executive Officer | 0.03% |
| Ilan Oren | Independent Chairperson | 0.02% |
| James Momtazee | Independent Director | 0.01% |
| Rakhi Kumar | Chief Accounting Officer | 0.01% |
| Richard Pulik | Chief Financial Officer | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-30 | Melissa Epperly | Independent Director | Derivative Exercise and Sale | -17,750 | $4.46–36.57 |
| 2026-09-29 | Frank Torti | Vant Chair | Other Acquisition | +40,309 | $36.57 |
| 2026-09-29 | Mayukh Sukhatme | President & Chief Investment Officer | Sale to Issuer | -46,879 | $36.57 |
| 2026-09-29 | Matthew Gline | Chief Executive Officer | Sale to Issuer | -76,171 | $36.57 |
| 2026-09-29 | Eric Venker | President | Derivative Exercise and Sale | -200,000 | $3.85–36.62 |
| 2026-09-19 | Richard Pulik | Chief Financial Officer | Sale to Issuer | -2,129 | $39.77 |
| 2026-09-19 | Jennifer Humes | Chief Accounting Officer | Sale to Issuer | -3,880 | $39.77 |
| 2026-09-15 | Meghan FitzGerald | Independent Director | Other Acquisition | +5,054 | -- |
| 2026-09-15 | Meghan FitzGerald | Independent Director | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-15 | Keith Manchester | Independent Director | Other Acquisition | +5,054 | -- |
| 2026-09-15 | Keith Manchester | Independent Director | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-15 | James Momtazee | Independent Director | Other Acquisition | +5,054 | -- |
| 2026-09-15 | James Momtazee | Independent Director | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-15 | Daniel Gold | Independent Director | Other Acquisition | +5,054 | -- |
| 2026-09-15 | Daniel Gold | Independent Director | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-15 | Melissa Epperly | Independent Director | Other Acquisition | +5,054 | -- |
| 2026-09-15 | Melissa Epperly | Independent Director | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-15 | Ilan Oren | Independent Chairperson | Other Acquisition | +5,054 | -- |
| 2026-09-15 | Ilan Oren | Independent Chairperson | Other Derivative Acquisition | +10,531 | $39.57 |
| 2026-09-14 | Meghan FitzGerald | Independent Director | Automatic Disposition | -5,112 | $39.68–40.45 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
罗万特科学 讨论区 0 条评论